Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
180.5 GBX | +1.98% | -3.22% | +18.75% |
Mar. 26 | EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend | AN |
Mar. 26 | CPPGroup Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 31.47 | 26.14 | 31.36 | 9.731 | 13.45 | 15.66 | - | - |
Enterprise Value (EV) 1 | 16.73 | 10.82 | 14.85 | -6.558 | 13.45 | 6.379 | 9.356 | 8.834 |
P/E ratio | - | - | 12.5 x | - | - | - | - | - |
Yield | - | 8.36% | 3.52% | - | - | - | - | - |
Capitalization / Revenue | 0.23 x | 0.19 x | 0.22 x | 0.06 x | 0.07 x | 0.09 x | 0.1 x | 0.1 x |
EV / Revenue | 0.12 x | 0.08 x | 0.1 x | -0.04 x | 0.07 x | 0.04 x | 0.06 x | 0.05 x |
EV / EBITDA | 2.9 x | 1.51 x | 1.97 x | -0.96 x | 2.81 x | 1.56 x | 3.39 x | 1.9 x |
EV / FCF | -49.4 x | 7.74 x | 3.68 x | -1.99 x | - | -0.65 x | -1.55 x | -3.32 x |
FCF Yield | -2.03% | 12.9% | 27.2% | -50.3% | - | -154% | -64.4% | -30.1% |
Price to Book | - | 1.78 x | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 8,646 | 8,742 | 8,833 | 8,846 | 8,847 | 8,847 | - | - |
Reference price 2 | 3.640 | 2.990 | 3.550 | 1.100 | 1.520 | 1.770 | 1.770 | 1.770 |
Announcement Date | 4/16/20 | 3/24/21 | 3/29/22 | 3/28/23 | 3/26/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 138.4 | 141.1 | 143.6 | 169.8 | 193 | 165.8 | 152.3 | 161.1 |
EBITDA 1 | 5.762 | 7.16 | 7.524 | 6.853 | 4.783 | 4.101 | 2.756 | 4.657 |
EBIT 1 | 2.137 | 3.665 | 4.529 | 4.346 | -0.666 | 0.7849 | -0.2893 | 1.435 |
Operating Margin | 1.54% | 2.6% | 3.15% | 2.56% | -0.35% | 0.47% | -0.19% | 0.89% |
Earnings before Tax (EBT) | 1.132 | 2.012 | - | - | - | - | - | - |
Net income | -1.009 | -1.68 | 2.565 | - | - | - | - | - |
Net margin | -0.73% | -1.19% | 1.79% | - | - | - | - | - |
EPS | - | - | 0.2843 | - | - | - | - | - |
Free Cash Flow 1 | -0.339 | 1.398 | 4.037 | 3.296 | - | -9.851 | -6.024 | -2.659 |
FCF margin | -0.25% | 0.99% | 2.81% | 1.94% | - | -5.94% | -3.96% | -1.65% |
FCF Conversion (EBITDA) | - | 19.53% | 53.65% | 48.1% | - | - | - | - |
FCF Conversion (Net income) | - | - | 157.39% | - | - | - | - | - |
Dividend per Share 2 | - | 0.2500 | 0.1250 | - | - | - | - | - |
Announcement Date | 4/16/20 | 3/24/21 | 3/29/22 | 3/28/23 | 3/26/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | 14.7 | 15.3 | 16.5 | 16.3 | - | 9.28 | 6.3 | 6.83 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -0.34 | 1.4 | 4.04 | 3.3 | - | -9.85 | -6.02 | -2.66 |
ROE (net income / shareholders' equity) | - | -10.7% | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets | - | - | - | - | - | - | - | - |
Book Value Per Share | - | 1.680 | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | 1.48 | 0.36 | - | - | - | - | - | - |
Capex / Sales | 1.07% | 0.25% | - | - | - | - | - | - |
Announcement Date | 4/16/20 | 3/24/21 | 3/29/22 | 3/28/23 | 3/26/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.75% | 19.51M | |
+38.91% | 61.52B | |
+10.77% | 50.24B | |
+11.58% | 48.88B | |
+21.42% | 44.86B | |
+22.26% | 33.96B | |
+9.76% | 29.23B | |
+50.11% | 27.95B | |
+21.08% | 24.78B | |
+8.72% | 20.56B |
- Stock Market
- Equities
- CPP Stock
- Financials CPPGroup Plc